The Effect of Bortezomib on Antibody Titers Against Common Viral and Vaccine Antigens
Description: 

The primary objective of this study is to determine whether bortezomib treatment affects the antibody titers against infectious diseases that patients are routine vaccinated against as children. A secondary objective is to examine antibody titers spontaneously recover followingcompletion of treatment.

Study Number: 

I 239513

Phase: 
I
Principal Investigator: 

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail askrpci@roswellpark.org.